ZIM Laboratories Limited

BSE:541400 Stock Report

Market Cap: ₹6.0b

ZIM Laboratories Balance Sheet Health

Financial Health criteria checks 6/6

ZIM Laboratories has a total shareholder equity of ₹2.4B and total debt of ₹973.5M, which brings its debt-to-equity ratio to 40.1%. Its total assets and total liabilities are ₹4.3B and ₹1.8B respectively. ZIM Laboratories's EBIT is ₹272.5M making its interest coverage ratio 3.2. It has cash and short-term investments of ₹58.1M.

Key information

40.1%

Debt to equity ratio

₹973.53m

Debt

Interest coverage ratio3.2x
Cash₹58.15m
Equity₹2.43b
Total liabilities₹1.85b
Total assets₹4.27b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 541400's short term assets (₹1.9B) exceed its short term liabilities (₹1.3B).

Long Term Liabilities: 541400's short term assets (₹1.9B) exceed its long term liabilities (₹540.4M).


Debt to Equity History and Analysis

Debt Level: 541400's net debt to equity ratio (37.7%) is considered satisfactory.

Reducing Debt: 541400's debt to equity ratio has reduced from 51.8% to 40.1% over the past 5 years.

Debt Coverage: 541400's debt is well covered by operating cash flow (30.7%).

Interest Coverage: 541400's interest payments on its debt are well covered by EBIT (3.2x coverage).


Balance Sheet


Discover healthy companies